Arcline Investment Management Acquires Polypeptide Therapeutic Solutions

Agreements, News, Press release

Arcline Investment Management (“Arcline”), a growth-oriented private equity firm with $4.3 billion of cumulative capital commitments, today announced the acquisition of Polypeptide Therapeutic Solutions, S.L. (“PTS” or “the Company”) from Columbus Venture Partners.   PTS is a leading GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications, including mRNA, DNA, cell therapies,…

PharmaIN Corporation and Polypeptide Therapeutic Solutions announces a collaboration agreement for contract manufacturing

Agreements

Bothell, WA & Valencia, Spain – 21st September 2018 PharmaIN Corporation and Polypeptide Therapeutic Solutions (PTS) announced today that they have entered into a collaboration agreement for contract manufacturing. Under the agreement, Polypeptide Therapeutic Solutions will provide PharmaIN contract research services and own technology to add as a part of PharmaIN´s Protected Graft Co-Polymer (PGCTM)…

Polypeptide Therapeutic Solutions and PMC Isochem sign business and technology collaboration agreement in the field of Cosmetic and Therapeutic Polypeptide

Agreements

Polypeptide Therapeutic Solutions and PMC Isochem sign business and technology collaboration agreement in the field of Cosmetic and Therapeutic Polypeptide. Under the agreement, Polypeptide Therapeutic Solutions will use proprietary technology and research capabilities to offer contract research services from the polypeptide design up to delivery of small quantity of polymer and PMC Isochem will use…